Skip to main content

Table 1 Baseline patient characteristics

From: Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer

Characteristics

No. of patients (%)

Median age year, (range)

69

(51–79)

Gender

 male

26

(86.7)

 female

4

(13.4)

Median BMI, (range)

22.2

(15.3–28.5)

Primary lesion

 Upper

8

(26.7)

 Middle

11

(36.7)

 Lower

11

(36.7)

Type of gastrectomy

 Proximal

2

(6.7)

 Distal

16

(53.3)

 Total

12

(40.0)

Macroscopic type

 1

1

(3.3)

 2

5

(16.7)

 3

22

(73.3)

 5

2

(6.7)

Differentiation

 well

2

(6.7)

 mod

12

(40.0)

 poor

16

(53.3)

Tumor stage

 3

14

(46.7)

 4a

16

(53.3)

Nodal stage

 1

2

(6.7)

 2

13

(43.3)

 3a

12

(40.0)

 3b

3

(10.0)

UICC stage

 IIIA

12

(40.0)

 IIIB

9

(30.0)

 IIIC

9

(30.0)